MarketCap
Facebook
X
TelegramQuarterly report 2023-Q1
added 05-11-2023
ViewRay Operating Income 2011-2026 | VRAY
Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.
FormulaOperating profit = Revenue – Operating expensesFeatures of the metric
- Evaluates business efficiency
Shows how well the company controls its production and administrative costs. - Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies. - Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.
If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.
Annual Operating Income ViewRay
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -107 M | -104 M | -106 M | -121 M | -75.1 M | -48.2 M | -44.2 M | -41.4 M | -31.6 M | -27.1 M | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -27.1 M | -121 M | -70.5 M |
Quarterly Operating Income ViewRay
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -29.6 M | - | - | - | -27.5 M | - | -23.3 M | -26.5 M | -24.7 M | - | -25 M | -25.6 M | -30.1 M | - | -31.7 M | -26.3 M | -30.4 M | - | -24.1 M | -18.2 M | -11.3 M | - | -11.6 M | -12.7 M | -11 M | - | -10.9 M | -10.7 M | -12.1 M | - | -9.08 M | -11.3 M | -8.03 M | - | -7.08 M | -1.82 K | -4.16 K | 471 | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 471 | -31.7 M | -17 M |
Operating Income of other stocks in the Medical devices industry
| Issuer | Operating Income | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Helius Medical Technologies
HSDT
|
-12.4 M | $ 2.22 | - | $ 1.35 M |  USA |
 |
OrthoPediatrics Corp.
KIDS
|
-39.2 M | $ 17.12 | - | $ 402 M | USA |
 |
LENSAR
LNSR
|
-24.6 M | $ 5.39 | - | $ 64.5 M | USA |
 |
Myomo
MYO
|
-14.4 M | $ 0.85 | - | $ 35.6 M | USA |
 |
Allied Healthcare Products
AHPI
|
-1.27 M | - | 3.58 % | $ 2.21 M | USA |
 |
Apollo Endosurgery
APEN
|
-31.4 M | - | - | $ 475 M | USA |
 |
Orthofix Medical
OFIX
|
-81.4 M | $ 12.19 | - | $ 483 M |  Curacao |
 |
Alphatec Holdings
ATEC
|
-82.1 M | $ 6.99 | - | $ 1.05 B | USA |
 |
EDAP TMS S.A.
EDAP
|
-20.5 M | $ 3.6 | - | $ 135 M |  France |
 |
Aziyo Biologics
AZYO
|
-26.9 M | - | 1.37 % | $ 20.5 M | USA |
 |
Avinger
AVGR
|
-16.6 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
-64.9 M | - | - | $ 3.31 B | USA |
 |
Insulet Corporation
PODD
|
474 M | $ 151.28 | - | $ 10.6 B | USA |
 |
BioSig Technologies
BSGM
|
-71.1 M | - | 37.08 % | $ 85.7 M | USA |
 |
BIOLASE
BIOL
|
-17.9 M | - | -13.19 % | $ 166 K | USA |
 |
Sintx Technologies
SINT
|
-10.7 M | $ 2.4 | - | $ 6.66 M | USA |
 |
Conformis
CFMS
|
-46.3 M | - | - | $ 16.4 M | USA |
 |
ClearPoint Neuro
CLPT
|
-24.2 M | $ 11.47 | - | $ 325 M | USA |
 |
Stryker Corporation
SYK
|
4.89 B | $ 292.33 | - | $ 112 B | USA |
 |
Cardiovascular Systems
CSII
|
-35.8 M | - | 0.15 % | $ 844 M | USA |
 |
TransMedics Group
TMDX
|
109 M | $ 72.92 | - | $ 2.48 B | USA |
 |
Cytosorbents Corporation
CTSO
|
-14.7 M | $ 0.57 | - | $ 35.5 M | USA |
 |
Tandem Diabetes Care
TNDM
|
8.29 M | $ 18.03 | - | $ 1.23 B | USA |
 |
LivaNova PLC
LIVN
|
199 M | $ 66.26 | - | $ 3.61 B |  Britain |
 |
Delcath Systems
DCTH
|
660 K | $ 11.26 | - | $ 403 M | USA |
 |
Neovasc
NVCN
|
-31.1 M | - | - | $ 111 M |  Canada |
 |
IRIDEX Corporation
IRIX
|
-2.57 M | $ 1.04 | - | $ 17.6 M | USA |
 |
Dynatronics Corporation
DYNT
|
-2.45 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
-112 M | - | - | $ 10.2 M | USA |
 |
Varex Imaging Corporation
VREX
|
-27.8 M | $ 12.17 | - | $ 504 M | USA |
 |
Electromed
ELMD
|
9.66 M | $ 25.94 | - | $ 219 M | USA |
 |
Vivos Therapeutics
VVOS
|
-19.9 M | $ 0.72 | - | $ 7.4 M | USA |
 |
Butterfly Network
BFLY
|
-74.4 M | $ 4.55 | - | $ 963 M | USA |
 |
Second Sight Medical Products
EYES
|
-27.6 M | - | -0.97 % | $ 54.4 M | USA |
 |
GBS
GBS
|
-10.6 M | - | -0.57 % | $ 7.12 M | USA |
 |
Globus Medical
GMED
|
480 M | $ 89.22 | - | $ 12.1 B | USA |
 |
CONMED Corporation
CNMD
|
103 M | $ 37.32 | - | $ 1.16 B | USA |
 |
Inspire Medical Systems
INSP
|
51 M | $ 45.7 | - | $ 1.34 B | USA |
 |
Integer Holdings Corporation
ITGR
|
221 M | $ 86.29 | - | $ 3 B | USA |
 |
Invacare Corporation
IVC
|
-80.5 M | - | - | $ 24.7 M | USA |